Genmab — Juni 2019
-
Tusinde tak Monforte...Du får plus i morgen.
-
God morgen
-
-
Hvorledes ser vi denne her? Den er blevet linket til før.
-
Celgene viser kliniske data for arvtager til super-blockbuster mod knoglemarvskræft
Amerikanske Celgene har fremlagt positive kliniske data for et nyt immunmodulerende middel til behandling af knoglemarvskræft, som ser ud til at kunne hjælpe patienter, når behandling med Genmabs Darzalex eller selskabets egen storsællert Revlimid fejler.
(medwatch.dk)
-
God morgen.
Hello! It looks like you're interested in this conversation, but you don't have an account yet.
Getting fed up of having to scroll through the same posts each visit? When you register for an account, you'll always come back to exactly where you were before, and choose to be notified of new replies (either via email, or push notification). You'll also be able to save bookmarks and upvote posts to show your appreciation to other community members.
With your input, this post could be even better 💗
Tilmeld Log ind